Dermalone (neomycin 2.5 mg / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 mg per 1 GM) Topical Ointment
RxNorm 2105785

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2105785 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Dermalone (neomycin 2.5 mg / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 mg per 1 GM) Topical Ointment.

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
Dermalone (neomycin (as neomycin sulfate) 2.5 mg / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 mg per 1 GM) Topical Ointment
AUI:10782100
View
PSN
Dermalone (neomycin 2.5 mg / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 mg per 1 GM) Topical Ointment
AUI:10782096
View
SBD
Neomycin 0.025 mg/MG / nystatin 100 UNT/MG / thiostrepton 2.5 UNT/MG / triamcinolone 0.001 mg/MG Topical Ointment [Dermalone]
AUI:12372080
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
Dermalone (neomycin (as neomycin sulfate) 2.5 mg / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 mg per 1 GM) Topical Ointment
(Atom ID: 10782100)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Dermalone (neomycin (as neomycin sulfate) 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 GM) Topical Ointment
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2105785
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
10782100
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2105785
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PSN

Prescribable Name (PSN):
Dermalone (neomycin 2.5 mg / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 mg per 1 GM) Topical Ointment
(Atom ID: 10782096)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Dermalone (neomycin 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 GM) Topical Ointment
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2105785
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
10782096
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2105785
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SBD

Semantic Branded Drug (SBD):
Neomycin 0.025 mg/MG / nystatin 100 UNT/MG / thiostrepton 2.5 UNT/MG / triamcinolone 0.001 mg/MG Topical Ointment [Dermalone]
(Atom ID: 12372080)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
neomycin 0.025 MG/MG / nystatin 100 UNT/MG / thiostrepton 2.5 UNT/MG / triamcinolone 0.001 MG/MG Topical Ointment [Dermalone]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2105785
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12372080
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
2105785
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{2105777} 7300
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2105778} 1365970
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{328439} 10761
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{646455} 7597
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2105777} 7299
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2105778} 1365970
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{328439} 10759
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{646455} 7597
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2105777} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2105778} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{328439} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{646455} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
11/28/2023
Date the RxNorm atom became obsolete
RXTERM FORM
Ointment
The RxTerm dose form name for this drug